.png){kind=icon}
返回
J
Jørgen Bjerggaard Jensen
aarhus university
46H指数
501论文数
8.5K被引数
收录论文 109
发表时间
.png){kind=icon}
Reply to Behzad Jazayeri, Xuefeng Wang, and Roger Li’s Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non–muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23–30回复Behzad Jazayeri、Xuefeng Wang和Roger Li致编辑的信件：关于Thomas Dreyer、Simone Brandt、Knud Fabrin等人撰写的“Xpert Bladder Cancer Monitor尿液生物标志物检测在指导高级别非肌层浸润性膀胱癌膀胱镜检查中的应用：DaBlaCa-15随机对照试验结果”一文。EUR UROL 2025;88:23–30。.png)
European Urology.png)
European UrologyIF25.2
PREAI
.png){kind=icon}
分享.png){kind=icon}
收藏Reply to Heidi Pharo, Hege Marie Vedeld, Rolf Wahlqvist, and Guro E. Lind’s Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23–30回复Heidi Pharo、Hege Marie Vedeld、Rolf Wahlqvist和Guro E. Lind致编辑的信函，关于：Thomas Dreyer、Simone Brandt、Knud Fabrin等人。Xpert Bladder Cancer Monitor尿液生物标志物检测在指导高危非肌层浸润性膀胱癌膀胱镜检查中的应用：来自随机对照DaBlaCa-15试验的结果。 Eur Urol 2025;88:23–30European Urology
European UrologyIF25.2
PREAI
分享收藏Reply to Xin Rui, Xiaoming Xu, and Bo Dai’s Letter to the Editor re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non–muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.03.018回复辛瑞、许小明和戴博的致编辑函，关于：Thomas Dreyer, Simone Brandt, Knud Fabrin等人。使用Xpert Bladder Cancer Monitor尿液生物标志物检测指导高危非肌层浸润性膀胱癌患者进行膀胱镜检查：来自随机对照DaBlaCa-15试验的结果。 Eur Urol. 已录用。 https://doi.org/10.1016/j.eururo.2025.03.018European Urology
European UrologyIF25.2
PREAI
分享收藏Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non–muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 TrialXpert Bladder Cancer Monitor尿液生物标志物检测用于指导高级别非肌层浸润性膀胱癌膀胱镜检查：来自随机对照DaBlaCa-15试验的结果European Urology
OAAI
European UrologyIF25.2
OAAI分享收藏Associations between patient sociodemographic characteristics and lack of treatment for locally advanced or metastatic urothelial carcinoma: results from a complete nationwide, unselected, real-world register study in Denmark患者社会人口学特征与局部晚期或转移性尿路上皮癌缺乏治疗之间的关联：丹麦一项完整的、全国性、未筛选的真实世界登记研究的成果BMC PUBLIC HEALTHOAAI
BMC PUBLIC HEALTHIF3.6
OAAI分享收藏